At a high‑profile meeting of the Chinese Academy of Sciences’ Life and Medical Sciences Division, leading researchers shared breakthrough work that could reshape health and agriculture. • Academician Zhu Lan recapped 40 years of pioneering work on female pelvic floor disorders, introducing a three‑tier prevention system that has cut urinary incontinence rates in half and rolled out cervical‑cancer programs to developing nations. Her next steps target fertility protection and digital health tools for mothers and children. • Young award‑winner Li Hanjie unveiled new types of human macrophages, shedding light on how these immune cells help blood vessels grow and maintain tissue balance. • Liu Xing presented a series of discoveries on how microbes trigger a special form of cell death (pyroptosis) in gut lining, identifying drug candidates that block harmful inflammation and improve survival in sepsis models. • Academician Fu Xiangdong described a “green‑revolution” strategy that engineers crops to use carbon and nitrogen far more efficiently, paving the way for AI‑guided, climate‑smart varieties. • Ma Kaiping called for a shift from planting more trees to restoring forest ecosystem functions, emphasizing biodiversity‑driven restoration. • Qu Lijia explained how tiny peptide‑receptor pathways can break long‑standing reproductive barriers in plants, opening doors to new hybrid crops. • Cai Xiujun showcased home‑grown, minimally invasive surgical tools—from biodegradable intestinal stents to robot‑assisted force feedback—offering cheaper, locally produced alternatives. • Fang Jingyuan highlighted the gut microbiome as a three‑level weapon against colorectal cancer, from preventive herbs to targeting harmful bacteria that fuel drug resistance. • Wang Yongjun introduced a “human‑centered” drug‑development platform that uses AI, organoids and virtual trials to speed stroke‑treatment discoveries. • Zeng Musheng outlined a novel EBV vaccine strategy that blocks the virus at two points and generates broad‑spectrum antibodies. • Zhou Jian detailed a precision‑medicine pipeline for liver cancer, combining liquid‑biopsy early detection with advanced surgery and relapse‑prevention tactics. The session sparked lively debate, drawing experts from across the academy and underscoring China’s push toward innovative, patient‑focused science.
Read more